HPVC2019-159 Biopharmaceuticals Long-Acting Granulocyte-Colony Stimulating Factor
- Contract Start Date
- 28 Jun 2019
- Contract End Date
- 27 Jun 2023
- Option Periods
- 1 x 2 years
DescriptionContract for the provision of long acting granulocyte colony-stimulating factor (G-CSF) to Victorian public hospitals and health services.
The Principal Period (2 years) commenced on 28 June 2019 until 27 June 2021.
The first Contract Option period of two years has been executed - effective from 28 June 2021 until 27 June 2023.
Option Periods Remaining
1 x 2 Years
Category 1: Biopharmaceuticals Long-Acting Granulocyte Colony-Stimulating Factor
Please favourite this contract to receive updates
Please review your account settings to ensure the notification frequency selected is adequate